Anzeige
Mehr »
Login
Mittwoch, 23.09.2020 Börsentäglich über 12.000 News von 646 internationalen Medien
GOLDPREIS-KORREKTUR zur richtigen Zeit! Diese Firma profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 883804 ISIN: CA69341D1042 Ticker-Symbol: N/A 
1-Jahres-Chart
VIVEVE MEDICAL INC Chart 1 Jahr
5-Tage-Chart
VIVEVE MEDICAL INC 5-Tage-Chart

Aktuelle News zur VIVEVE MEDICAL Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
VIVEVE MEDICAL Aktie jetzt für 0€ handeln
DiViveve Medical issued method patent for stress urinary incontinence-
DiVIVEVE MEDICAL, INC. - 8-K, Current Report-
01.09.VIVEVE MEDICAL, INC. - 8-K, Current Report5
25.08.Viveve Medical News: Why VIVE Stock Is Rocketing 48% Today3
25.08.Mid-Day Market Update: Dow Tumbles 170 Points; Viveve Medical Shares Spike Higher-
25.08.iBio and Viveve Medical among healthcare gainers; Proteostasis Therapeutics among losers46
25.08.The Daily Biotech Pulse: Altimmune Reports Positive Preclinical Data For Intranasal COVID-19 Vaccine, AbbVie Licenses Morphic's Drug, Viveve Clinical Readout23
25.08.Viveve Medical up big on revival of RF treatment for urinary incontinence8
25.08.Viveve Medical, Inc.: Viveve Announces Positive Primary Efficacy Data from its SUI Feasibility Study and Positive Preclinical Outcomes that Support the Company's New Sham Tip for Pivotal PURSUIT Trial234Achievement of primary efficacy endpoint in 3-arm SUI feasibility study demonstrates significant separation between CMRF treatment arm and inert sham arm Positive in-vivo preclinical study validates...
► Artikel lesen
25.08.VIVEVE MEDICAL, INC. - 8-K, Current Report3
14.08.Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2020 Results - Earnings Call Transcript2
13.08.Viveve Medical, Inc.: Viveve Reports Second Quarter 2020 Financial Results and Provides Corporate Update351Advanced critical SUI feasibility study for late summer readout Achieved FDA clearance to conduct pivotal SUI PURSUIT Trial Company to host conference call at 5:00 PM ET today ENGLEWOOD, CO /...
► Artikel lesen
13.08.VIVEVE MEDICAL, INC. - 8-K, Current Report1
23.07.VIVEVE MEDICAL, INC. - 8-K, Current Report1
14.07.VIVEVE MEDICAL, INC. - 8-K, Current Report-
07.07.Viveve on go with study of CMRF treatment for stress urinary incontinence2
07.07.BRIEF-Viveve Medical Announces FDA Approval To Conduct Pursuit Trial For Improvement Of Stress Urinary Incontinence2
07.07.VIVEVE MEDICAL, INC. - 8-K, Current Report-
30.06.VIVEVE MEDICAL, INC. - 8-K, Current Report1
29.06.Viveve Medical, Inc.: Viveve Medical Announces Adjournment of Annual Meeting1.032Meeting scheduled to reconvene July 22, 2020 at 10:30 AM Eastern Time ENGLEWOOD, CO / ACCESSWIRE / June 29, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's...
► Artikel lesen
Seite:  Weiter >>
59 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1